[Clinical course, therapy and malignant transformation of lymphogranulomatosis X (including (angio)immunoblastic lymphadenopathy)].
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001706:Biopsy; D002471:Cell Transformation, Neoplastic / Q000473:pathology*; D004359:Drug Therapy, Combination; D006689:Hodgkin Disease / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D007119:Immunoblastic Lymphadenopathy / Q000188:drug therapy / Q000473:pathology*; D008198:Lymph Nodes / Q000473:pathology; D008223:Lymphoma / Q000188:drug therapy / Q000473:pathology*; D011379:Prognosis
D000970:Antineoplastic Agents
Verlauf, Therapie und maligne Transformation der Lymphogranulomatosis X (einschliesslich [angio]immunoblastischer Lymphadenopathie).